Ophthalmologists at Harvard Medical School and Boston’s Mass Eye and Ear teaching hospital discovered evidence that semaglutide.
The active component of weight-loss miracle medications like Ozempic and Wegovy, may sometimes result in blindness.
Two distinct groups of researchers from the University of Southern Denmark have now published studies that support the conclusions obtained by the ophthalmologists at Harvard Medical School.
Non-arteritic anterior ischemic optic neuropathy, or NAION for short, is a rare eye condition that has been linked to GLP-1 drugs like Ozempic in all three investigations.
It results in abrupt and irreversible eyesight loss. A decrease in blood flow to the optic nerve is the cause of NAION.
NAION is the second most frequent type of blindness caused by injury to the optic nerve, behind glaucoma, and affects thousands of people.
